Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950170-25-107414·Turnstone Biologics Corp.
Schedule 13D ownership disclosure
TURNSTONE BIOLOGICS CORP
Common Stock, $0.001 par value per share · CUSIP: 90042W100
Event date: 2025-08-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Versant Venture Capital V, L.P.Reported CIK 0001589097
Shares: 0 · Class: 0.0%
- Versant Affiliates Fund V, L.P.Reported CIK 0001589095
Shares: 0 · Class: 0.0%
- Versant Ophthalmic Affiliates Fund I, L.P.Reported CIK 0001589098
Shares: 0 · Class: 0.0%
- Versant Ventures V, LLCReported CIK 0001619298
Shares: 0 · Class: 0.0%
- Versant Venture Capital V (Canada) LPReported CIK 0001612235
Shares: 0 · Class: 0.0%
- Versant Ventures V GP-GP (Canada), Inc.Reported CIK 0001619297
Shares: 0 · Class: 0.0%
- Versant Ventures V (Canada), L.P.Reported CIK 0001716490
Shares: 0 · Class: 0.0%
- Versant Vantage II, L.P.Reported CIK 0001832235
Shares: 0 · Class: 0.0%
- Versant Vantage II GP, L.P.Reported CIK 0001839790
Shares: 0 · Class: 0.0%
- Versant Vantage II GP-GP, LLCReported CIK 0001839789
Shares: 0 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-107414
- Form type
- SCHEDULE 13D/A
- Filer
- Turnstone Biologics Corp.
- CIK
- CIK 1764974
- Filed
- Aug 12, 2025
- Reporting period
- Aug 08, 2025
- Description
- Schedule 13D beneficial ownership